SGC-CBP30 - 98%, high purity , CAS No.1613695-14-9, Inhibitor of CREB binding protein;Inhibitor of E1A binding protein p300

Item Number
S357869
Grouped product items
SKUSizeAvailabilityPrice Qty
S357869-5mg
5mg
3
$98.90
S357869-10mg
10mg
3
$147.90
S357869-25mg
25mg
2
$333.90
S357869-50mg
50mg
1
$444.90
S357869-100mg
100mg
1
$751.90

Basic Description

Specifications & PurityMoligand™, ≥98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of CREB binding protein;Inhibitor of E1A binding protein p300
Product Description

Product introduction

SGC-CBP30 is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects.

AI Insight

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid504772253
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504772253
IUPAC Name 4-[(2S)-1-[2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)benzimidazol-1-yl]propan-2-yl]morpholine
INCHI InChI=1S/C28H33ClN4O3/c1-18(32-11-13-35-14-12-32)17-33-25-8-7-22(28-19(2)31-36-20(28)3)16-24(25)30-27(33)10-6-21-5-9-26(34-4)23(29)15-21/h5,7-9,15-16,18H,6,10-14,17H2,1-4H3/t18-/m0/s1
InChi Key GEPYBHCJBORHCE-SFHVURJKSA-N
Canonical SMILES CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)CC(C)N5CCOCC5
Isomeric SMILES CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)C[C@H](C)N5CCOCC5
PubChem CID 72201027
Molecular Weight 509.04

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
G2209334Certificate of AnalysisApr 03, 2025 S357869
G2209335Certificate of AnalysisApr 03, 2025 S357869
G2209337Certificate of AnalysisApr 03, 2025 S357869
G2209338Certificate of AnalysisApr 03, 2025 S357869
G2209344Certificate of AnalysisApr 03, 2025 S357869

Related Documents

Reviews

Customer Reviews

References

1. Hammitzsch A, Tallant C, Fedorov O, O'Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M et al..  (2015)  CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses..  Proc Natl Acad Sci USA,  112  (34): (10768-73).  [PMID:26261308] [10.1021/op500134e]
2. Chua MJ, Robaa D, Skinner-Adams TS, Sippl W, Andrews KT.  (2018)  Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites..  Int J Parasitol Drugs Drug Resist,  (2): (189-193).  [PMID:29631126] [10.1021/op500134e]

Solution Calculators